Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin
Titel:
Exenatide Twice Daily Plus Glargine Versus Aspart 70/30 Twice Daily in Patients With Type 2 Diabetes With Inadequate Glycemic Control on Premixed Human Insulin and Metformin
Auteur:
Chen, Xi Xu, Yongping Zhang, Jianhua Shao, Shiyin Duan, Yanran Liu, Peiwen Shen, Liya Zhang, Jing Zeng, Jiaoe Lin, Mei Zhao, Shi Ma, Jianhua Zhao, Tao Hu, Juping Liao, Yong Chen, Xiaowen Hu, Shufang Xue, Yaoming Zeng, Zhaoyang He, Wentao Liu, Zhelong Li, Wenjun Liu, Liegang Yin, Ping Yu, Xuefeng